435 related articles for article (PubMed ID: 19776736)
1. Drug development perspective on pharmacokinetic studies of new drugs in patients with renal impairment.
Lalonde RL; Wagner JA
Clin Pharmacol Ther; 2009 Nov; 86(5):557-61. PubMed ID: 19776736
[TBL] [Abstract][Full Text] [Related]
2. A systematic comparison of cockcroft-gault and modification of diet in renal disease equations for classification of kidney dysfunction and dosage adjustment.
Park EJ; Wu K; Mi Z; Dong T; Lawrence JP; Ko CW; Huang SM; Zhang L; Crentsil V; Zhang J; Xu NN
Ann Pharmacother; 2012 Sep; 46(9):1174-87. PubMed ID: 22932303
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the Modification of Diet in Renal Disease and Cockcroft-Gault equations for dosing antimicrobials.
Hermsen ED; Maiefski M; Florescu MC; Qiu F; Rupp ME
Pharmacotherapy; 2009 Jun; 29(6):649-55. PubMed ID: 19476418
[TBL] [Abstract][Full Text] [Related]
4. Continuing the use of the Cockcroft-Gault equation for drug dosing in patients with impaired renal function.
Spruill WJ; Wade WE; Cobb HH
Clin Pharmacol Ther; 2009 Nov; 86(5):468-70. PubMed ID: 19844221
[No Abstract] [Full Text] [Related]
5. Low-molecular-weight heparins in renal impairment and obesity: available evidence and clinical practice recommendations across medical and surgical settings.
Nutescu EA; Spinler SA; Wittkowsky A; Dager WE
Ann Pharmacother; 2009 Jun; 43(6):1064-83. PubMed ID: 19458109
[TBL] [Abstract][Full Text] [Related]
6. Regulatory perspectives on designing pharmacokinetic studies and optimizing labeling recommendations for patients with chronic kidney disease.
Zhang L; Xu N; Xiao S; Arya V; Zhao P; Lesko LJ; Huang SM
J Clin Pharmacol; 2012 Jan; 52(1 Suppl):79S-90S. PubMed ID: 22232757
[TBL] [Abstract][Full Text] [Related]
7. Medication dosing errors in hospitalized patients with renal impairment: a study in Palestine.
Sweileh WM; Janem SA; Sawalha AF; Abu-Taha AS; Zyoud SH; Sabri IA; Al-Jabi SW; Jaradat NA; Zaid AA
Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):908-12. PubMed ID: 17464934
[TBL] [Abstract][Full Text] [Related]
8. Tailor-made drug treatment for children: creation of an infrastructure for data-sharing and population PK-PD modeling.
Ince I; de Wildt SN; Tibboel D; Danhof M; Knibbe CA
Drug Discov Today; 2009 Mar; 14(5-6):316-20. PubMed ID: 19059496
[TBL] [Abstract][Full Text] [Related]
9. Strength of evidence for labeled dosing recommendations in renal impairment.
Gagne JJ; Khan NF; Raj TS; Patel LR; Choudhry NK
Clin Trials; 2017 Apr; 14(2):219-221. PubMed ID: 27780884
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the impact of renal impairment on systemic exposure of new molecular entities: evaluation of recent new drug applications.
Zhang Y; Zhang L; Abraham S; Apparaju S; Wu TC; Strong JM; Xiao S; Atkinson AJ; Thummel KE; Leeder JS; Lee C; Burckart GJ; Lesko LJ; Huang SM
Clin Pharmacol Ther; 2009 Mar; 85(3):305-11. PubMed ID: 19020495
[TBL] [Abstract][Full Text] [Related]
11. Dose adjustment guidelines for medications in patients with renal impairment: how consistent are drug information sources?
Khanal A; Castelino RL; Peterson GM; Jose MD
Intern Med J; 2014 Jan; 44(1):77-85. PubMed ID: 24112311
[TBL] [Abstract][Full Text] [Related]
12. When to conduct a renal impairment study during drug development: US Food and Drug Administration perspective.
Huang SM; Temple R; Xiao S; Zhang L; Lesko LJ
Clin Pharmacol Ther; 2009 Nov; 86(5):475-9. PubMed ID: 19844224
[TBL] [Abstract][Full Text] [Related]
13. Use of the MDRD study equation to estimate kidney function for drug dosing.
Stevens LA; Levey AS
Clin Pharmacol Ther; 2009 Nov; 86(5):465-7. PubMed ID: 19844220
[No Abstract] [Full Text] [Related]
14. International Society of Geriatric Oncology (SIOG) recommendations for the adjustment of dosing in elderly cancer patients with renal insufficiency.
Lichtman SM; Wildiers H; Launay-Vacher V; Steer C; Chatelut E; Aapro M
Eur J Cancer; 2007 Jan; 43(1):14-34. PubMed ID: 17222747
[TBL] [Abstract][Full Text] [Related]
15. Drug dosage adjustment in hospitalized patients with renal impairment at Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia.
Getachew H; Tadesse Y; Shibeshi W
BMC Nephrol; 2015 Oct; 16():158. PubMed ID: 26446847
[TBL] [Abstract][Full Text] [Related]
16. Drug dosing in patients with renal insufficiency. A simplified approach.
Bakris GL; Talbert R
Postgrad Med; 1993 Dec; 94(8):153-6, 159-60, 163-4. PubMed ID: 8247992
[TBL] [Abstract][Full Text] [Related]
17. Applications of population pharmacokinetics in current drug labelling.
Duan JZ
J Clin Pharm Ther; 2007 Feb; 32(1):57-79. PubMed ID: 17286790
[TBL] [Abstract][Full Text] [Related]
18. A quantitative approach to drug dosing in chronic kidney disease.
Olyaei AJ; Steffl JL
Blood Purif; 2011; 31(1-3):138-45. PubMed ID: 21228582
[TBL] [Abstract][Full Text] [Related]
19. Impact of a renal drug dosing service on dose adjustment in hospitalized patients with chronic kidney disease.
Hassan Y; Al-Ramahi RJ; Aziz NA; Ghazali R
Ann Pharmacother; 2009 Oct; 43(10):1598-605. PubMed ID: 19776297
[TBL] [Abstract][Full Text] [Related]
20. Drug dosing based on weight and body surface area: mathematical assumptions and limitations in obese adults.
Pai MP
Pharmacotherapy; 2012 Sep; 32(9):856-68. PubMed ID: 22711238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
